Brie Carere
Known title: DirectorCIK: 0001763095
Associated companies
Transaction History
| FDX | ▲ Buy | Grant | 4,734 | $0 | 6/25/2026 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 32,997 | $0 | 6/9/2026 | View on chart |
| FDX | ▼ Sell | Open Market | 2,700 | $999K | 4/14/2026 | View on chart |
| FDX | ▲ Buy | Grant | 6,325 | $0 | 6/26/2025 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 20,429 | $0 | 6/10/2025 | View on chart |
| FDX | ▼ Sell | Open Market | 1,958 | $608K | 7/18/2024 | View on chart |
| FDX | ▲ Buy | Grant | 3,320 | $0 | 6/27/2024 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 15,004 | $0 | 6/11/2024 | View on chart |
| FDX | ▲ Buy | Grant | 3,959 | $0 | 6/22/2023 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 11,077 | $0 | 6/13/2023 | View on chart |
| FDX | ▼ Sell | Open Market | 1,750 | $406K | 4/10/2023 | View on chart |
| FDX | ▲ Buy | Option Exercise | 3,805 | $620K | 8/12/2022 | View on chart |
| FDX | ▲ Buy | Option Exercise | 4,930 | $1.0M | 8/12/2022 | View on chart |
| FDX | ▲ Buy | Option Exercise | 2,500 | $405K | 8/12/2022 | View on chart |
| FDX | ▼ Sell | Open Market | 11,235 | $2.6M | 8/12/2022 | View on chart |
| FDX | ▲ Buy | Grant | 2,940 | $0 | 6/30/2022 | View on chart |
| ZIP | ▲ Buy | Option Exercise | 2,582 | $0 | 6/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking
FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking. FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.